← Back to Search

Behavioral Intervention

Virtual Trauma Support for Autistic Adults with PTSD

N/A
Recruiting
Research Sponsored by University of Wyoming
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change across baseline to follow-up (an average of 6 months)
Awards & highlights

Study Summary

This trial will study the initial efficacy and feasibility of telehealth-delivered WET for autistic adults with trauma symptoms. Participants will receive WET & provide feedback for future modifications.

Who is the study for?
This trial is for autistic adults over 18 who have experienced trauma and show significant traumatic stress symptoms. They must be comfortable with English, have basic internet access for telehealth visits, and score at least 65 on an intelligence test (WASI-2). Those not meeting these criteria or posing a safety risk are excluded.Check my eligibility
What is being tested?
The study tests the effectiveness of Written Exposure Therapy (WET) delivered via telehealth to reduce PTSD symptoms in autistic adults. It's a pre-post single group design where participants wear Fitbits and attend virtual sessions to assess changes in mental health, physical health, and biobehavioral indicators.See study design
What are the potential side effects?
While specific side effects are not listed for WET, participants may experience discomfort when recalling traumatic events during therapy sessions. The use of Fitbit involves minimal risks related to privacy concerns.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change across baseline to follow-up (an average of 6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change across baseline to follow-up (an average of 6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in posttraumatic stress disorder (PTSD) symptoms on the Posttraumatic Symptom Checklist for DSM-5 (PCL-5) Scale
Secondary outcome measures
Change in PTSD symptoms on the clinician-administered Structured Clinical Interview for DSM-5
Change in anxiety symptoms on the Anxiety Scale for Autism-Adults (ASA-A)
Change in camouflaging on the Camouflaging Autistic Traits Questionnaire (CATQ)
+14 more
Other outcome measures
Change in autistic quality of life on the Autism Spectrum Quality of Life Scale.
Change in overall quality of life on the World Health Organization Quality of Life Scale
Change in positive Autistic identity on the Autism Spectrum Identity Scale (ASIS)
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Written Exposure TherapyExperimental Treatment1 Intervention
Behavioral therapy: Written Exposure Therapy via telehealth

Find a Location

Who is running the clinical trial?

University of WyomingLead Sponsor
17 Previous Clinical Trials
1,407 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still availability for participation in this experiment?

"Yes, according to information available on clinicaltrials.gov this study is presently recruiting participants. The listing was initially posted on March 31st 2023 and last amended on May 7th 2023. Thirty patients must be enrolled from one medical centre for the trial's completion."

Answered by AI

How many participants are engaged in this investigation?

"Affirmative. According to clinicaltrials.gov, this trial is currently in the process of recruitment and was first uploaded on March 31st 2023 with its latest update being 7th May 2023. The project needs 30 participants from a single site."

Answered by AI

Who else is applying?

What state do they live in?
Kansas
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

It sounds beneficial.
PatientReceived 1 prior treatment
~20 spots leftby May 2025